News

gut.bmj23h
IDDF2024-ABS-0066 Novel peptides derived from sutterella wadsworthensis potentiating the efficacy of PD-1 blockade on colorectal cancer
Engineering Research Center of Applied Technology of Pharmacogenomics (Ministry of Education), Hunan Key Laboratory of Pharmacomicrobiomics, Department of Clinical Pharmacology, Xiangya Hospital, ...
gut.bmj1d
The role of gut microbiota in cancer treatment: friend or foe?
Correspondence to Dr Jun Yu, Institute of Digestive Disease and The Department of Medicine and Therapeutics, Chinese University of Hong Kong, New Territories, Hong Kong; junyu{at}cuhk.edu.hk The gut ...
gut.bmj2d
O10 What do patients think of cytosponge? Survey of 299 patients in a new nurse-run service
Introduction Due to pandemic restrictions we established a new early diagnosis service for patients with reflux symptoms and those on our existing Barrett’s surveillance programme using Cytosponge as ...
gut.bmj3d
Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN
Correspondence to Dr Eileen Morgan, International Agency for Research on Cancer, 69372 Lyon CEDEX 08, France; morgane{at}iarc.who.int Objective Colorectal cancer (CRC) is the third most common cancer ...
gut.bmj5d
YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition
Correspondence to Shumei Song, Departmental of GI Medical Oncology, U.T.MD. Anderson Cancer Center, Houston, TX 77030, USA; ssong{at}mdanderson.org; Jaffer A Ajani ...
gut.bmj6d
Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets
1 Department of Gastroenterology and Hepatology, Academic Medical Centre, Amsterdam, the Netherlands 2 Department of Experimental Internal Medicine, Academic Medical Centre, Amsterdam, the Netherlands ...
gut.bmj6d
Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning?
Correspondence to: P V Kirjavainen, Functional Foods Forum, University of Turku, FIN-20014 Turku, Finland; pirkka.kirjavainen{at}utu.fi Background: Recent data have outlined a relationship between the ...
gut.bmj6d
Perspective on enhancing CRC risk prediction
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
gut.bmj6d
Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma
Objective To characterise gut microbiome in patients with hepatocellular carcinoma (HCC) and evaluate the potential of microbiome as non-invasive biomarkers for HCC. Design We collected 486 faecal ...
gut.bmj6d
Sensitivity to wheat, gluten and FODMAPs in IBS: facts or fiction?
Correspondence to Professor Peter Gibson, Department of Gastroenterology, Alfred Hospital, 99 Commercial Road, Melbourne Victoria 3004, Australia; peter.gibson{at}monash.edu IBS is one of the most ...
gut.bmj6d
Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort
2 Lille Inflammation Research International Center LIRIC—UMR 995 Inserm/Université Lille 2/CHRU de Lille; Equipe «IBD and environmental factors: epidemiology and functional analyses, Lille University, ...
gut.bmj7d
Accuracy of a no-biopsy approach for the diagnosis of coeliac disease across different adult cohorts
Objective We aimed to determine the predictive capacity and diagnostic yield of a 10-fold increase in serum IgA antitissue transglutaminase (tTG) antibody levels for detecting small intestinal injury ...